复方虫草多糖脂质体口服液抗肝纤维化临床观察

Clinical Observation of Compound Cordyceps Sinensis Liposome Oral Liquid in Treatment of Liver Fibrosis

目的:研究复方虫草多糖脂质体口服液(简称:CCSOL)抗肝纤维化的疗效。方法:治疗组43例,对照组40例,两组均给予六合氨基酸、维生素类护肝药物,治疗组加用CCSOL,观察治疗前后血清ALT、BILIT、HA、LN、C-IV指标变化情况。结果:治疗后,治疗组与对照组比较肝纤维化指标明显改善(JP<0.05)。结论:CCSOL能够有效改善肝脏的微循环状态,保护肝细胞,促进受损肝细胞恢复和肝功能复常。

Objective： Tostudy the therapeutic effects ofthe compound Cordycepssinensis oral liquid in treatment of anti-fibrosis of liver. Methods： The therapeutic group （23 cases） and the controlled group （20 cases） were all given ordinary medicine of protecting liver, and the therapeutic group was also given the compound Cordyceps sinensis oral liquid. Before and after therapy, the ALT, SB, HA, LN, C-IV between the groups were observed. ResuIts： After the therapy, the indexes of fibrosis in the therapeutic group had a better impro-vement than the controlled group. Conclusion： The compound Cordyceps sinensis oral liquid can improve the liverblood circulation andprotect the livercells, it can also protect the liveranti-fibrosis.